FDA Inspection 1204910 — CSL Plasma Inc.
The FDA completed an inspection of CSL Plasma Inc. on April 14, 2023 in Houston, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- April 14, 2023
- Fiscal Year
- 2023
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- Houston, TX (United States)